
Korean Patients With Parkinson Disease May Have a Greater Risk of Skin Cancer
Korean patients with Parkinson disease were found to be at greater risk of developing skin cancer, with male and older populations considered higher-risk groups, according to study findings published this week.
Korean patients with
Although prior research has indicated that patients with PD (PwP) have a
The study authors sought to investigate the association between PD and skin cancer in underrepresented Asian populations, who also typically have lighter skin pigmentations. The researchers conducted a nationwide population-based study, examining data from 70,780 patients from Korea with newly diagnosed PD between January 2010 and December 2015. PwP were compared with a control group of 353,900 sex and age-matched patients without PD.
In the study findings, Korean PwP were found to be at a nearly 17% greater risk than the non-PD group (overall HR, 1.169; 95% CI, 1.005-1.359). Additionally, age and sex played a prominent factor in determining risk of skin cancer as male PwP aged 65 or older exhibited a 2.8 times greater risk for melanoma development than the non-PD group (HR, 2.825; 95% CI, 1.395-5.721). Female PwP were also found to be at a 1.3 times greater risk of developing nonmelanoma skin cancer than the non-PD group (HR, 1.305; 95% CI, 1.073-1.589).
Because notable differences in risk based on race, age, and sex signal potential at-risk groups, further studies may be warranted to confirm associations. Especially because the present study results conflict eith earlier findings that PwP have a lower cancer risk.
“Compared with the general population, Korean patients diagnosed with PD had a greater risk of skin cancer. Especially, male patients aged 65 years and above and diagnosed with PD had a significant risk of melanoma development compared with control,” said the study authors.
Reference
Ryu HJ, Park JH, Choi M, et al. Parkinson disease and skin cancer risk: a nationwide population-based cohort study in Korea [published online April 14, 2020]. J Eur Acad Dermatol Venereol. doi: 10.1111/jdv.16462.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.